𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Obstetric emergencies precipitated by malignant brain tumors

✍ Scribed by Krishnansu Sujata Tewari; Fabio Cappuccini; Tamerou Asrat; Bruce L. Flamm; Sidney E. Carpenter; Philip J. DiSaia; Edward J. Quilligan

Book ID
113981915
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
96 KB
Volume
182
Category
Article
ISSN
1097-6868

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Interstitial hyperthermia of malignant b
Interstitial hyperthermia of malignant brain tumors by implant heating system: Clinical experience
✍ Tastuya Kobayashi; Yoshihisa Kida; Takayuki Tanaka; Kazuyoshi Hattori; Masaaki M πŸ“‚ Article πŸ“… 1991 πŸ› Springer US 🌐 English βš– 845 KB

An implant heating system using a ferromagnetic implant with low Curie temperature has been developed for treating human brain tumors. Safe and repeated hyperthermia was possible over periods averaging ten weeks in 23 out of 25 patients with malignant brain tumors without development of major side e

The emerging role of irinotecan (CPT-11)
The emerging role of irinotecan (CPT-11) in the treatment of malignant glioma in brain tumors
✍ Henry S. Friedman; Stephen T. Keir; Peter J. Houghton πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 68 KB πŸ‘ 1 views

Irinotecan is a water-soluble derivative of camptothecin, an alkylator originally extracted from the Chinese tree Camptotheca acuminata. Laboratory studies have demonstrated the activity of irinotecan in a broad panel of pediatric and adult central nervous system tumor xenografts in athymic nude mic

Enhanced chemotherapy delivery by intraa
Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors : The Sherbrooke experience
✍ David Fortin; Annick Desjardins; Andrew Benko; Theophylle Niyonsega; Marie Boudr πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 385 KB

## Abstract ## BACKGROUND The treatment of malignant brain tumors is hampered by the presence of the blood‐brain barrier, which limits chemotherapy penetration to the central nervous system (CNS). In recent years, different strategies have been designed to circumvent this physiologic barrier. The